Clearmind Medicine receives approval to continue phase I trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. HOOD
8. DFTX
9. USO
10. MSFT

Go back to Clearmind Medicine receives approval to continue phase I trial
(NASDAQ: CMND) Delayed: 2.96 -0.11 (3.58%)
Previous Close $3.07    52 Week High $ 
Open $3.08    52 Week Low $ 
Day High $3.11    P/E N/A 
Day Low $2.92    EPS $ 
Volume 255,573